Overview

  • Product nameAnacardic acid
  • Description
    Histone acetyltransferase (HAT) inhibitor
  • Biological descriptionInhibits HAT activity of p300 and p300/CREB-binding protein-associated factor (pCAF) (IC50 = 8.5 and 5 μM, respectively). Suppresses NF-κB activation, inhibits IκBα phosphorylation and prohibits p65 nuclear translocation
  • Purity> 98%

Properties

    References for Anacardic acid (ab120892)

    This product has been referenced in:
    • Omanakuttan A  et al. Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9. Mol Pharmacol 82:614-22 (2012). Read more (PubMed: 22745359) »
    • Sung B  et al. Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis. Blood 111:4880-91 (2008). Read more (PubMed: 18349320) »
    • Balasubramanyam K  et al. Small molecule modulators of histone acetyltransferase p300. J Biol Chem 278:19134-40 (2003). Read more (PubMed: 12624111) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120892.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"